Understanding the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum

Active Project Grant Awarded Last action

Award ID
HT94252510051
Recipient
Awarding agency
Obligated
$3,333,240

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 35% complete
Place of performance
Allegheny-West, PA 15212, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

This $3,333,240 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research by the Allegheny Singer Research Institute (AHN Research Institute) to study the effects of intracavitary conditioning in breast cancer metastatic to the pleura or peritoneum. The grant period runs from June 1, 2025 through May 31, 2029. The research aims to develop innovative medical solutions that address critical health challenges relevant to military personnel and civilian populations. As a not-for-profit medical research organization, the Allegheny Singer Research Institute has a track record of executing federal contracts and grants, including partnerships with academic institutions, to advance complex biomedical investigations across various scientific disciplines.

Quick answers

Who received award HT94252510051?

HT94252510051 was awarded to Allegheny Singer Research Institute by Defense Health Agency (Department of Defense) on June 1, 2025.

How much is award HT94252510051 worth?

$3,333,240 has been obligated on HT94252510051.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login